Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Amir Shbeeb

Anesthesiology Long Beach, CA Medical Doctor

NPI 1700143617 CMS profile 1397833

5901 E 7Th St, Long Beach, CA 90822

Open in the dashboard

General payments

$216,418

239 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Amir Shbeeb of Long Beach, CA is reported in the CMS Open Payments database as having received $216,418 across 239 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,204 11
2024 General $6,447 8
2023 General $49,357 54
2022 General $73,676 76
2021 General $71,708 74
2020 General $5,815 13
2019 General $4,213 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amir Shbeeb
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Amir Shbeeb were reported at $5,204. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Amir Shbeeb Anesthesiology median Middle half National median
2019 $4,213 $72 $23–$151 $163
2020 $5,815 $36 $17–$120 $114
2021 $71,708 $49 $21–$135 $132
2022 $73,676 $52 $22–$144 $149
2023 $49,357 $53 $23–$143 $160
2024 $6,447 $55 $25–$150 $164
2025 $5,204 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Pacira Pharmaceuticals Incorporated $191,390 199 payments
  2. Edwards Lifesciences Corporation $10,675 12 payments
  3. Baxter Healthcare $6,795 2 payments
  4. Becton, Dickinson and Company $4,300 3 payments
  5. Verathon Inc. $1,375 1 payment
  6. Zimmer Biomet Holdings, Inc. $482 9 payments
  7. Fisher & Paykel Healthcare Inc $377 3 payments
  8. Vertex Pharmaceuticals Incorporated $377 3 payments
  9. Heron Therapeutics, Inc. $201 2 payments
  10. Chiesi USA, Inc. $144 1 payment
  11. Other $302 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $117,210 38 payments
  2. Honoraria $61,245 19 payments
  3. Travel and Lodging $28,223 81 payments
  4. Food and Beverage $5,670 97 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,070 4 payments
Products named General payments · program years 2019–2025
  1. Exparel Pain Management $186,076 187 payments
  2. Iovera $10,291 19 payments
  3. Zilretta Pain Management $7,220 12 payments
  4. Fluid Systems - Drug Delivery Systems $3,995 1 payment
  5. HemoSphere $3,800 4 payments
  6. Fluid Systems - Infusion Systems $2,800 1 payment
  7. EXPAREL Pain Management $2,795 7 payments
  8. FloTrac Sensor $400 1 payment
  9. SWAN-GANZ $400 1 payment
  10. Zilretta Pain Management $400 1 payment
  11. Other $3,379 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 10 billing codes

Paid by Medicare

$1,705

Medicare's payments for the services billed

Medicare patients

11

Average age 70

Services billed

15

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Exparel
  • Pacira Pharmaceuticals Incorporated $5,198
$5,198 — —
Zilretta
  • Pacira Pharmaceuticals Incorporated $133
$133 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

239 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record